Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2025-06-06 00:00:00 ET · period of report 2025-06-06 · accession 0001628280-25-030078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-06 | 2025-06-06 | VIR | BISCHOFBERGER NORBERT W | Dir | J - Other | $0.00 | +10.7K | 10.7K | New | $0 |
| 2025-06-06 | 2025-06-06 | VIR | BISCHOFBERGER NORBERT W | Dir | J - Other | $0.00 | -10.7K | 13.3K | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-06 | J | A | 10,667 | $0.00 | 10,667 | I | — | — | |
| 2 | Common | Common Stock | 2025-06-06 | J | D | 10,667 | $0.00 | 13,333 | D See footnote | — | — | (F2) The shares are held in the name of Nextquest, LLC, of which the Reporting Person is a managing member. |